What is the ticker symbol for Onconetix?

Onconetix trades under the ticker ONCO on NASDAQ.

What sector does Onconetix operate in?

Onconetix is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ONCO in a portfolio?

PortView shows ONCO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Onconetix (ONCO) Stock Analysis

NASDAQHealthcareBiotechnology

$0.66+1.44%

1-year price historyRange $0.61 – $206.00

52-week range$0.66

$0.59$209.50

What Onconetix does

Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The company's product lineup includes Entadfi, an FDA-cleared, once-daily oral medication. This prescription drug combines finasteride and tadalafil to manage benign prostatic hyperplasia (BPH). In its development pipeline, Onconetix is advancing a Streptococcus pneumoniae vaccine candidate, designed to prevent infectious middle ear infections in children and pneumonia in the elderly. Additionally, they are working on a universal influenza vaccine intended to provide comprehensive protection against all aggressive strains of the flu virus. Furthermore, Onconetix holds a license for an advanced norovirus S&P nanoparticle virus-like particle (VLP) vaccine platform from Cincinnati Children's. This adaptable platform is being leveraged to create vaccines for various infectious diseases, such as Marburg and monkeypox, among others. Established in 2018, the company was previously known as Blue Water Biotech, Inc., before changing its name to Onconetix, Inc. in December 2023. Its corporate headquarters are located in Cincinnati, Ohio.

Key metrics

Market cap

$2.37M

P/E (TTM)

-0.01

EPS (TTM)

$-45.63

Beta

2.69

Dividend yield

0.00%

Revenue / share

$0.29

50-day avg

$0.85

200-day avg

$35.72

52-week high

$209.50

52-week low

$0.59

CEO

David Allan White

ETFs linked to ONCO

Broad-market and Healthcare sector ETFs an investor holding Onconetix is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ONCO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ONCO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Onconetix?: Onconetix trades under the ticker ONCO on NASDAQ.
Which exchange is ONCO listed on?: ONCO is listed on NASDAQ.
What sector does Onconetix operate in?: Onconetix is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ONCO in a portfolio?: PortView shows ONCO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.